Viiv

Quote






Anything associated with Fink was ways a failure. Her time at Sanofi was especially horrific. She was gifted the job at Novartis but was quickly escorted out of the building after 14 months. Her wrecking ball management style then moved onto ViiV. Your looking at the damage today from this. It wasn't like you were warned. If GSK had done their homework and background checks you would see the infliction that she brought to the organization.
 






anonymous said:
Anything associated with Fink was ways a failure. Her time at Sanofi was especially horrific. She was gifted the job at Novartis but was quickly escorted out of the building after 14 months. Her wrecking ball management style then moved onto ViiV. Your looking at the damage today from this. It wasn't like you were warned. If GSK had done their homework and background checks you would see the infliction that she brought to the organization.
Click to expand...

Fink is Einhorn
 
























Can anyone tell me about the SAM positions in the East? Are they selling the new prevention drug or all drugs? Is this a good position for a 10 year rep? Serious replys greatly apprietated...
 












anonymous said:
The heat is coming down which I completely get. Since July 2017 when we went to 3 per pod (the furthest thing from specialty sales ever) we have seen the following:

1. Recycled RSDs from respiratory who popped into ViiV, bury us in metrics, and then head to RTP. Plenty of examples where their districts were bottom 10% and they ran off talent and micromanaged the rest—and got promoted after 2 yrs.

2. Senior leaders who built the positive culture retired (Bill Collier, Marlon Pittman, etc.). Instead we got Pickett and the GSK crew.

3. Bailed on Triumeq while we had decent share for 2DR (Juluca, Dovato, Cabenuva, and the entire future pipeline combined don’t equal the amount that Triumeq/Tivicay LOST and are still losing. I doubt the entire 2DR sales—all drug sales combined will EVER reach over $200m total (net) while the several billion dollar Triumeq and Tivicay, 1-2 punch keeps bleeding a fortune. Of course TAF hurt Tivicay (remember when Tivicay+Descovy was what IDs said was the gold standard). Well—GILEAD listened and Biktarvy faced no competition (we were doomed).

4. Metrics hell with number of programs, calls, bathroom breaks literally micromanaged. And the never break your 3-4 week routing ever.

5. Going from 3 up to 4 up. What next, can we go 5 up? That should fix things, lol.

At the end of the day, we lost all respect with IDs and in the HIV advocacy community for pushing the 2DR regimen (with 48wk data initially, then 96wk, etc.) when the standard of care was and is 3DR.

Why are we surprised? I am not. In hindsight I wish my RSD had pushed me out or let me take early retirement.
Click to expand...
 












As we become a New GSK we can already see upper leadership jumping ship. High flying Hal Barron just hit the eject lever. The same guy who was publicly shamed for expensing hundreds of thousands of dollars on air travel and 5 star hotels realizes that it's all coming to an end. You will see others on our leadership team leaving as well. Stick your head in the sand, that is your right. Rumor on the street is that once our divesture of our OTC business is complete, GSK will be bought and sold off in parts. Enjoy the next year or two. We will all be working for a new company by 2024.
 






anonymous said:
As we become a New GSK we can already see upper leadership jumping ship. High flying Hal Barron just hit the eject lever. The same guy who was publicly shamed for expensing hundreds of thousands of dollars on air travel and 5 star hotels realizes that it's all coming to an end.
Click to expand...

Yep, just the same way a tick sucks up so much blood that it gets so bloated it just can't hang on anymore.
 












Same shit show - hard to get product restricted access and FRM team destroying every ounce of respect in the community. There was no need for 3 HIV teams let alone 2 injectable teams selling the same drug. Who are they kidding if they think the call decks are different for a Dovato and Cabenuva doctor and a PREP team is calling on different doctors WTF? No just stop. This company lost their damn minds and treats their sales force like entry level primary care reps! Run away quickly. Get out the ship has sailed and is going nowhere
 












He seemed to be looking like Bruce Jenner going into the transition. Nothing wrong with that but not something most of us see up close. He’s a nice enough person. AND he and Colleen were smart enough to jump off the miserable sh@t-show that is Viiv. I too was unhappy at viiv and resigned (while doing well) and got nothing but criticism. Management talks out of both sides of their mouths; “leave if your not happy, but if your not happy and you leave then you suck”. Crazy-toxic work environment. Life is better after leaving. Just ask me, Colleen, Marlon, The Brit……
 






























Top Bottom
Back
Quote